DNA Methylation Profiling to Predict Recurrence Risk in Stage I Lung Adenocarcinoma: Development and Validation of a Nomogram to Optimize Clinical Management
2020 ◽
Vol 24
(13)
◽
pp. 7576-7589
2018 ◽
Vol 33
◽
pp. 17-23
◽
2016 ◽
Vol 99
(3)
◽
pp. 555-566
◽
Keyword(s):